Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology

Anton Pottegård; Lucas Morin; Jesper Hallas; Tobias Gerhard; Almut G. Winterstein; Susanna Perez-Gutthann; Mina Tadrous

doi:10.1002/pds.5382

Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology

Anton Pottegård^*, Lucas Morin, Jesper Hallas, Tobias Gerhard, Almut G. Winterstein, Susanna Perez-Gutthann, Mina Tadrous

^*Kontaktforfatter for dette arbejde

Klinisk farmakologi, farmaci og Miljømedicin

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Pharmacoepidemiology and Drug Safety
Vol/bind	31
Udgave nummer	2
Sider (fra-til)	257-259
ISSN	1053-8569
DOI	https://doi.org/10.1002/pds.5382
Status	Udgivet - feb. 2022

Dokumenter og links

10.1002/pds.5382

Citationsformater

@article{b99832d8c0844292bd3e5ccff39e4abc,

title = "Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology",

author = "Anton Potteg{\aa}rd and Lucas Morin and Jesper Hallas and Tobias Gerhard and Winterstein, {Almut G.} and Susanna Perez-Gutthann and Mina Tadrous",

year = "2022",

month = feb,

doi = "10.1002/pds.5382",

language = "English",

volume = "31",

pages = "257--259",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "JohnWiley & Sons Ltd.",

number = "2",

}

Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology. / Pottegård, Anton; Morin, Lucas; Hallas, Jesper; Gerhard, Tobias; Winterstein, Almut G.; Perez-Gutthann, Susanna; Tadrous, Mina.

I: Pharmacoepidemiology and Drug Safety, Bind 31, Nr. 2, 02.2022, s. 257-259.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

TY - JOUR

T1 - Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology

AU - Pottegård, Anton

AU - Morin, Lucas

AU - Hallas, Jesper

AU - Gerhard, Tobias

AU - Winterstein, Almut G.

AU - Perez-Gutthann, Susanna

AU - Tadrous, Mina

PY - 2022/2

Y1 - 2022/2

U2 - 10.1002/pds.5382

DO - 10.1002/pds.5382

M3 - Comment/debate

C2 - 34738294

AN - SCOPUS:85119119295

VL - 31

SP - 257

EP - 259

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 2

ER -